CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-13 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,466 | $12.14 | $139K | 389,268 |
| 2026-11-13 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,466 | $28.93 | $332K | 377,802 |
| 2026-11-13 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,466 | 0 | ||
| 2026-11-12 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-12 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −11,881 | $29.40 | $349K | 377,802 |
| 2026-11-12 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 11,466 | ||
| 2026-11-11 | BOBULSKY SUSAN Chief Commercial Officer, MRD | Sale 10b5-1 | −1,875 | $32.00 | $60K | 387,475 |
| 2026-11-11 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-11 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −4,983 | $30.29 | $151K | 384,700 |
| 2026-11-11 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −6,898 | $31.22 | $215K | 377,802 |
| 2026-11-11 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 23,347 | ||
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −9,981 | $29.35 | $293K | 379,702 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,900 | $30.41 | $58K | 377,802 |
| 2026-11-10 | RUBINSTEIN JULIE President and COO | Option exercise · Stock Option (right to buy) 10b5-1 | −11,881 | 35,228 | ||
| 2026-11-09 | ROBINS CHAD M CEO and Chairman | Gift | −100,000 | 2,080,518 | ||
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Option exercise 10b5-1 | +11,881 | $12.14 | $144K | 389,683 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −1,100 | $28.87 | $32K | 388,583 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −8,381 | $30.15 | $253K | 380,202 |
| 2026-11-09 | RUBINSTEIN JULIE President and COO | Sale 10b5-1 | −2,400 | $30.58 | $73K | 377,802 |
Page 1 of 120 · 2,386 trades